Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Mar 2008 07:01 AM
RNS
Research Update
06 Mar 2008 07:00 AM
RNS
Interim Results
04 Feb 2008 07:00 AM
RNS
Notice of Results
12 Dec 2007 07:01 AM
RNS
Genentech Agreement
30 Nov 2007 07:00 AM
RNS
Total Voting Rights
19 Nov 2007 07:00 AM
RNS
Director/PDMR Shareholding
16 Nov 2007 07:01 AM
RNS
Board Appointment
15 Nov 2007 03:07 PM
RNS
Placing of Shares
15 Nov 2007 12:59 PM
RNS
AGM Statement
31 Oct 2007 03:58 PM
RNS
Total Voting Rights
26 Oct 2007 04:35 PM
RNS
Director/PDMR Shareholding
24 Oct 2007 12:24 PM
RNS
Placing of shares
22 Oct 2007 07:01 AM
RNS
Fundraising
16 Oct 2007 04:33 PM
RNS
Annual Report and AGM notice
08 Oct 2007 11:01 AM
RNS
Holding(s) in Company
02 Oct 2007 07:01 AM
RNS
Research Update
02 Oct 2007 07:01 AM
RNS
Preliminary Results
21 Sep 2007 07:01 AM
RNS
Directorate Change
13 Sep 2007 09:42 AM
RNS
Notice of Results
16 Aug 2007 07:00 AM
RNS
Disclosure of Information
30 Jul 2007 07:02 AM
RNS
Extention of Collaboration
18 Jun 2007 12:34 PM
RNS
Directorate Change
15 May 2007 07:00 AM
RNS
Cancer Program Update
06 Feb 2007 07:01 AM
RNS
Research Programme Update
06 Feb 2007 07:00 AM
RNS
Interim Results
31 Jan 2007 11:08 AM
RNS
Total Voting Rights
22 Jan 2007 07:00 AM
RNS
Collaboration with J&J
12 Jan 2007 07:00 AM
RNS
Notice of Results & Update
08 Jan 2007 07:00 AM
RNS
New Investment in Sareum
18 Dec 2006 04:39 PM
RNS
Total Voting Rights
20 Nov 2006 07:00 AM
RNS
Agreement with Genentech
30 Oct 2006 04:23 PM
RNS
Issue of Equity
19 Oct 2006 05:40 PM
RNS
Board Change
19 Oct 2006 10:43 AM
RNS
AGM Statement
09 Oct 2006 07:00 AM
RNS
Significant Collaboration
26 Sep 2006 07:00 AM
RNS
Roche Cancer Collaboration
25 Sep 2006 04:37 PM
RNS
Posting of accounts
04 Sep 2006 07:01 AM
RNS
Preliminary Results
31 Aug 2006 07:00 AM
RNS
Cancer Drug Collaboration
15 Aug 2006 07:00 AM
RNS
Collaboration with Lundbeck
13 Jul 2006 07:00 AM
RNS
Extension of Collaboration
20 Jun 2006 07:01 AM
RNS
Collaboration with Sirtris
14 Jun 2006 09:45 AM
RNS
Holding(s) in Company
08 Jun 2006 07:00 AM
RNS
Success with Schering AG
28 Mar 2006 05:38 PM
RNS
Holding(s) in Company
08 Mar 2006 01:08 PM
RNS
Holding(s) in Company
23 Feb 2006 07:00 AM
RNS
Interim Results
16 Feb 2006 12:30 PM
RNS
Exercise of option
16 Feb 2006 10:51 AM
RNS
Notice of Results
13 Feb 2006 04:26 PM
RNS
Exercise of option

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings